Agenda
Thursday−Saturday,
September 24−26, 2026
Plan your conference experiences. Explore CME/CE courses, Industry Theaters, and relevant primary care topics for your practice.
Agenda to Come
Register NowDates
Filter by type
Additional registration is required for workshops
Speakers
Jennifer B. Green, MD
Professor of Medicine, Department of Medicine, Division of Endocrinology, Faculty Member, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine
Download the Pri-Med Events – USA Mobile App
- View the full agenda, learn about your expert faculty, and explore the Exhibit Hall
- Submit your burning questions and participate in live Q&A
- Claim your CME/CE credits, download session slides, and leave feedback
Financial Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Jennifer B. Green, MD
- Consultant: Anji, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, Valo, Vertex, Vertex; Researcher: Bluedrop, Boehringer Ingelheim, Merck, Roche
- BJ Miller, MD
- No relevant financial relationships disclosed.
- Charles Vega, MD, FAAFP
- Consultant: GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
Other Disclosures
Ty Gluckman, MD, MHA (Moderator): Consultant for OptumRx
Greg Hall, MD (Moderator): Health Equity Board for Exact Sciences
Pamela Kushner, MD, FAAFP (Reviewer and Moderator): Speaker and Advisor for GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Haleon, Corcept; Speaker for Phathom, Janssen; Advisor for Bausch/Salix, Bayer, Verdiva, Abbott
Charles Vega, MD, FAAFP (Moderator): Consultant for GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.